Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Nov 07, 2018 11:00am

144 Views

Post# 28937027

Analia; got me undressed.

Well. Its a good post Analia.

My wet dreams, I still believe that they are based on solid facts, with sales that are slower than anticipated by some.....me included, but the thing is moving in the right direction.

So, yes, your "dont become a pumper..." is a good one....

I am on that side: confident, and willing ton wait, without selling nothing right now. I think the potential TH is oversold right now.

FTV.

Bullboard Posts

FE Battery Metals begins 2024 winter drill program